Literature DB >> 27940724

Use of Reflux Medications in Premature Infants After Hospital Discharge.

P Brian Smith1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27940724      PMCID： PMC5127077          DOI： 10.1542/peds.2016-2849

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   9.703


× No keyword cloud information.
  15 in total

Review 1.  A quality improvement approach to optimizing medication use in the neonatal intensive care unit.

Authors:  Dan L Ellsbury; Robert Ursprung
Journal:  Clin Perinatol       Date:  2012-01-11       Impact factor: 3.430

2.  Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants.

Authors:  Ronnie Guillet; Barbara J Stoll; C Michael Cotten; Marie Gantz; Scott McDonald; W Kenneth Poole; Dale L Phelps
Journal:  Pediatrics       Date:  2006-01-03       Impact factor: 7.124

3.  Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants.

Authors:  Eva Wheatley; Kathleen A Kennedy
Journal:  J Pediatr       Date:  2009-06-21       Impact factor: 4.406

4.  H2-blocker therapy and incidence of necrotizing enterocolitis in preterm infants: a case-control study.

Authors:  Angeliki Bilali; Petros Galanis; Christos Bartsocas; Loukas Sparos; Emmanouil Velonakis
Journal:  Pediatr Neonatol       Date:  2013-03-05       Impact factor: 2.083

Review 5.  Proton pump inhibitor use in infants: FDA reviewer experience.

Authors:  Ii-Lun Chen; Wen-Yi Gao; Aisha P Johnson; Ali Niak; John Troiani; Joyce Korvick; Nancy Snow; Kristina Estes; Amy Taylor; Donna Griebel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-01       Impact factor: 2.839

Review 6.  Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review.

Authors:  Anna Maria Hibbs; Scott A Lorch
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

7.  Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns.

Authors:  Gianluca Terrin; Annalisa Passariello; Mario De Curtis; Francesco Manguso; Gennaro Salvia; Laura Lega; Francesco Messina; Roberto Paludetto; Roberto Berni Canani
Journal:  Pediatrics       Date:  2011-12-12       Impact factor: 7.124

8.  Histamine-2 receptor blockers alter the fecal microbiota in premature infants.

Authors:  Raegan W Gupta; Lynn Tran; Johana Norori; Michael J Ferris; A Murat Eren; Christopher M Taylor; Scot E Dowd; Duna Penn
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-04       Impact factor: 2.839

9.  Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.

Authors:  Susan R Orenstein; Eric Hassall; Wanda Furmaga-Jablonska; Stuart Atkinson; Marsha Raanan
Journal:  J Pediatr       Date:  2008-12-03       Impact factor: 4.406

10.  Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.

Authors:  William F Malcolm; Marie Gantz; Richard J Martin; Ricki F Goldstein; Ronald N Goldberg; Charles M Cotten
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124
View more
  1 in total

1.  Impact of Infant-Polysomnography Studies on Discharge Management and Outcomes: A 5 Year Experience from a Tertiary Care Unit.

Authors:  Ahmed Fageer Osman; Biju Thomas; Nakul Singh; Marc Collin; Prem Singh Shekhawat
Journal:  J Neonatal Biol       Date:  2017-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.